Do Mesenchymal stem cells enhance risk of tumor?
The most terrifyingqualm regarding mesenchymal stem cell treatment that indeed forces patients to abstain from this form of treatment is the questionable risk of increasing the formation of cancerous tumors by the therapy. It is defensible in case of embryonic stem cell therapy where the cells divide irrepressibly and speedilythus enhancing the risk as well as incidence of cancer-causing tumors in animals and humans. Pointless to say that embryonic stem cell therapy is consequently strictly banned by law in most nations. At StemCellCareIndia, we promise a cancer-risk free treatment as our treatment encompassesallogeneic stem cells which have verified to be non-carcinogenic.The following facts can clear your fears regarding the cancer-causing prospective of the adult stem cell therapy:
Mesenchymal stem cells therapy does not lead toamplified tumor risk unless the patient is suffering from cancer before the treatment. These cells are relocated shortly after withdrawal followed by purification and concentration for only therapeutic commitments.The following applies to therapy with Allogeneic/Adult Mesenchymal stem cells:
Allogeneic/Adult Mesenchymal stem cells, which are transplanted instantaneously after their elimination and concentration for therapeutic purposes, do not upsurge the risk of tumor unless the patient already has cancer.
No signs of higher tumor development have been found to exist over the last 40 years in the therapy of leukemia and lymphoma, which also encompasses the use of adult stem cells.
The conduct of adult stem cells depends to a great extent on their surroundings. There is no proof to date that adult stem cells endorse tumor formation in the human body. There is oneexception. The growth of a prevailing tumor can be endorsed by the addition of adult stem cells and tissue that is impaired by radioactivity can stabilize into cancerous tissue after the inoculation of adult stem cells.
Adult stem cells only tend to form cancerous stem cells if they are permissible to reproduce in a culture dish over a drawn-out period of time, since the likelihood of genetic defect clusters upsurges in proportion to the number of cell divisions.
In a pre-clinical tumorogenicity study in mice, no augmented risk was found.
In line with the latest scientific findings, the therapy executed at our center does not cause tumors as the stem cells are mature cells (in disparity with embryonic cells) and are not permitted to multiply for any length of time outside the body. They are relocated back into the body instantaneously after purification. StemCellCareIndia doesn’t treat patients with tumors.Relying on the latest findings of contemporary research, we can securely state that our treatment does not upsurge the risk of tumors or cause them because of the fact that we use adult stem cells rather than embryonic cells. We take every precaution to decrease the cancer risks to zero by safeguarding prevention of multiplication of cells because ofinstantaneous transplant post purification and concentration. Regrettably, our policy strictly forbids treatment of patients with cancerous as well as benign tumors.